NovaBridge Biosciences American Depositary Shares
NBP
16 hedge funds and large institutions have $60.8M invested in NovaBridge Biosciences American Depositary Shares in 2020 Q1 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
6% more ownership
Funds ownership: 0% → 6% (+6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$12.5M |
| 2 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$10.4M |
| 3 |
SCM
Sio Capital Management
New York
|
+$5.91M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$5.09M |
| 5 |
AG
Artal Group
Luxembourg
|
+$4.37M |
Top Sellers
NBP Hedge Fund Activity: Q1 2020 in Review
16 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q1 2020, worth a combined $60.8M.
Buyers outnumbered sellers: 16 funds opened new NBP positions and 0 closed out — a net gain of 16 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $12.5M.
- 16 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q1 2020, up from 0 in Q4 2019.
- Funds reported $60.8M of NovaBridge Biosciences American Depositary Shares stock for Q1 2020.
- 16 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q1 2020 and 0 closed out, a net change of +16 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q1 2020 was Adage Capital Partners, an estimated $12.5M added.
Based on aggregated 13F filings for Q1 2020.